subscribe
 

Dosing initiated in Phase I/II clinical trial of APR-246 in ovarian cancer

Swedish ovarian cancer proof-of-concept trial begins dosing



Novartis receives EU approval for Ilaris®

Novartis receives EU approval for Ilaris® in active Systemic Juvenile Idiopathic Arthritis, a serious form of childhood arthritis



Novartis receives positive CHMP opinion for Ilaris®

Novartis receives positive CHMP opinion for Ilaris® in active Systemic Juvenile Idiopathic Arthritis, a serious form of childhood arthritis.



Retina implant AG’s Alpha IMS wins CE mark

Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), has announced that its wireless subretinal implant technology, the Alpha IMS, has received CE Mark.



New 2-3 day patient-applied product for sun-damaged skin that can lead to skin cancer

A new treatment for sun-damaged skin that can lead to skin cancer is launched by LEO Pharma



Inflatable leg wraps cut clot risk after stroke, study shows

Stroke patients at risk of blood clots and death could be helped by a compression device that wraps around the legs, a study suggests.



Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe